在Acinetobacter spp. 的研究中, 在新生儿败血症:迫切的全球威胁
Kamla Pillay1,2, Anirban Ray-Chaudhuri3, Seamus O'Brien4
1Institute of Infection & Immunity, St George's, University of London, London, United Kingdom.
Frontiers in antibiotics
|January 16, 2025
概括
来自多药耐药性Acinetobacter菌株的新生儿败血症威胁着婴儿的生存,特别是在低收入国家. 迫切需要进行研究,以对抗这些难以治疗的感染,并减少婴儿死亡率.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 新生儿败血症是导致死亡和残疾的主要原因,不成比例地影响低收入国家.
- 多种耐药性病原体,特别是Acinetobacter物种,对全球新生儿构成越来越大的威胁.
- 青杆菌菌株经常抵抗世界卫生组织推的第一线抗生素,使治疗复杂化.
研究的目的:
- 审查Acinetobacter物种在新生儿败血症中的作用.
- 总结全球流行病学,临床特征和促成因素 (宿主,病原体,环境).
- 讨论当前和未来的治疗策略和研究重点.
主要方法:
- 对新生儿败血症中Acinetobacter的研究的文献综述.
- 全球流行病学和临床数据的分析.
- 综合有关抗微生物耐药性和治疗挑战的信息.
主要成果:
- 全球范围内,Acinetobacter物种是新生儿严重败血症的日益严重的原因.
- 常见的抗生素,如安培素和 gentamicin 的耐药性是常见的.
- 抗卡巴胺抗性巴菌 (CRAB) 的出现带来了严重的治疗困难.
结论:
- 乙杆菌感染对新生儿的生存构成了关键挑战,特别是在资源有限的环境中.
- 现有的治疗方法往往是无效的,新生儿的新疗法选择有限.
- 对临床方面,传播和预防的进一步研究对于减少新生儿死因败血症的死亡率至关重要.
相关概念视频
01:27Acute Pyelonephritis I: Introduction
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...